Cargando…

Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient

The continuous flow, enantioselective, organophotoredox catalytic asymmetric alkylation of aldehydes was studied, by using a homemade, custom‐designed photoreactor for reactions under cryogenic conditions. Going from microfluidic conditions up to a 10 mL mesofluidic reactor, an increase of productiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Herbrik, Fabian, Sanz, Miguel, Puglisi, Alessandra, Rossi, Sergio, Benaglia, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325444/
https://www.ncbi.nlm.nih.gov/pubmed/35239197
http://dx.doi.org/10.1002/chem.202200164
_version_ 1784757053465559040
author Herbrik, Fabian
Sanz, Miguel
Puglisi, Alessandra
Rossi, Sergio
Benaglia, Maurizio
author_facet Herbrik, Fabian
Sanz, Miguel
Puglisi, Alessandra
Rossi, Sergio
Benaglia, Maurizio
author_sort Herbrik, Fabian
collection PubMed
description The continuous flow, enantioselective, organophotoredox catalytic asymmetric alkylation of aldehydes was studied, by using a homemade, custom‐designed photoreactor for reactions under cryogenic conditions. Going from microfluidic conditions up to a 10 mL mesofluidic reactor, an increase of productivity by almost 18000 % compared to the batch reaction was demonstrated. Finally, for the first time, a stereoselective photoredox organocatalytic continuous flow reaction in a fully telescoped process for an active pharmaceutical ingredient (API)synthesis was successfully achieved. The final process consists of four units of operation: visible light‐driven asymmetric catalytic benzylation under continuous flow, inline continuous work‐up, neutralisation and a final oxidative amidation step afforded the pharmaceutically active molecule in 95 % e.e.
format Online
Article
Text
id pubmed-9325444
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93254442022-07-30 Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient Herbrik, Fabian Sanz, Miguel Puglisi, Alessandra Rossi, Sergio Benaglia, Maurizio Chemistry Research Articles The continuous flow, enantioselective, organophotoredox catalytic asymmetric alkylation of aldehydes was studied, by using a homemade, custom‐designed photoreactor for reactions under cryogenic conditions. Going from microfluidic conditions up to a 10 mL mesofluidic reactor, an increase of productivity by almost 18000 % compared to the batch reaction was demonstrated. Finally, for the first time, a stereoselective photoredox organocatalytic continuous flow reaction in a fully telescoped process for an active pharmaceutical ingredient (API)synthesis was successfully achieved. The final process consists of four units of operation: visible light‐driven asymmetric catalytic benzylation under continuous flow, inline continuous work‐up, neutralisation and a final oxidative amidation step afforded the pharmaceutically active molecule in 95 % e.e. John Wiley and Sons Inc. 2022-05-04 2022-06-10 /pmc/articles/PMC9325444/ /pubmed/35239197 http://dx.doi.org/10.1002/chem.202200164 Text en © 2022 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Herbrik, Fabian
Sanz, Miguel
Puglisi, Alessandra
Rossi, Sergio
Benaglia, Maurizio
Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient
title Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient
title_full Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient
title_fullStr Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient
title_full_unstemmed Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient
title_short Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient
title_sort enantioselective organophotocatalytic telescoped synthesis of a chiral privileged active pharmaceutical ingredient
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325444/
https://www.ncbi.nlm.nih.gov/pubmed/35239197
http://dx.doi.org/10.1002/chem.202200164
work_keys_str_mv AT herbrikfabian enantioselectiveorganophotocatalytictelescopedsynthesisofachiralprivilegedactivepharmaceuticalingredient
AT sanzmiguel enantioselectiveorganophotocatalytictelescopedsynthesisofachiralprivilegedactivepharmaceuticalingredient
AT puglisialessandra enantioselectiveorganophotocatalytictelescopedsynthesisofachiralprivilegedactivepharmaceuticalingredient
AT rossisergio enantioselectiveorganophotocatalytictelescopedsynthesisofachiralprivilegedactivepharmaceuticalingredient
AT benagliamaurizio enantioselectiveorganophotocatalytictelescopedsynthesisofachiralprivilegedactivepharmaceuticalingredient